On Jan. 22, Secretary Xavier Becera sent a letter to Medicare plans, payers, and state Medicaid and CHIP agencies about upholding their obligations under federal law, coinciding with the 51st anniversary of Roe v. Wade.
Three notes:
- A new set of guidelines to help payers meet existing federal obligations by fully covering a broader range of FDA-approved contraceptives and some devices.
- Updates to the Medicare Part D formulary clinical review process for plan year 2024 to include additional birth control types and intrauterine devices for future plan years.
- Instructing local Medicare administrative contractors to publish educational content on the availability of IUD coverage for certain conditions under Medicare Part B.
